As a neuropathic pain treatment drug, the use of Tarlige requires strict attention to the risk of neurological side effects and contraindications. This drug may cause adverse reactions such as dizziness and drowsiness, and may interact with multiple drugs. Special populations need to adjust the dosage. The following provides a detailed explanation of precautions in terms of side effect management and contraindications.

1. Management of neurological side effects

About 30% of patients experience dizziness or drowsiness, and it is recommended to avoid driving for 8 hours after the first medication. Taking medication before bedtime can reduce daytime fatigue. If accompanied by unstable gait, seek medical attention. A small number of patients have reported memory impairment or attention deficit, and it is necessary to evaluate whether a reduction is needed.

2 Digestive system responses

The incidence of nausea and vomiting is about 15% -20%, and it is recommended to take it with a small amount of food. Continuous diarrhea requires monitoring of electrolytes, as a high-fat diet can delay drug absorption. After vomiting, there is no need to take additional medication, but it is important to ensure that the next dosing interval is normal.

3. Handling of Skin Allergic Reactions

The incidence of rash is 5% -10%. If severe reactions such as blisters and peeling occur, the medication should be stopped immediately. Skin swelling or mucosal damage indicates allergic dermatitis, requiring emergency treatment and permanent discontinuation. Avoid direct sunlight during medication to prevent photosensitive reactions.

4 Contraindications Warning

Patients with severe liver injury are prohibited from using it, as metabolic disorders can easily lead to poisoning. Pregnancy is absolutely contraindicated, and women of childbearing age should use non hormonal contraceptive measures. Breastfeeding should be suspended during lactation as medication may be secreted through breast milk.

5 Prevention of Drug Interactions

Prohibition of combination with central nervous system inhibitors (such as opioids) may exacerbate respiratory depression. Strong inducers of CYP3A4 may reduce efficacy and require dosage adjustment. Taking it with alcohol can enhance its sedative effect, and alcohol should be avoided during the medication period.

6 Medication adjustments for special populations

The starting dose for elderly people should be halved, and for those with renal insufficiency, the dosing interval should be extended. Patients with depression need to monitor their suicidal tendencies during the early stages of medication, while those with a history of epilepsy should be alert to an increase in seizure frequency. Patients with mild liver function abnormalities need to undergo regular transaminase testing.